Info
13F
Schedule 13D
Ownership

General Atlantic, L.P. - Significant Ownership

Signature - Title: /s/ Michael Gosk - Michael Gosk, Managing Director
Location: New York, NY
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by General Atlantic, L.P..

Significant Ownership of General Atlantic, L.P.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
ALKT	ALKAMI TECHNOLOGY, INC.	Common stock, par value $0.001 per share	9.6%	$253M		9.67M		General Atlantic, L.P.	Dec 31, 2024
AKRO	Akero Therapeutics, Inc.	Common Stock, par value $0.0001 per share	8.4%	$279M		6.8M		General Atlantic, L.P.	Mar 31, 2025
BLND	Blend Labs, Inc.	Class A common stock, par value $0.00001 per share	0%	$0		0		General Atlantic, L.P.	Dec 31, 2024
THRD	Third Harmonic Bio, Inc.	Common stock, par value $0.0001	0%	$0	-$18.7M	0	-100%	General Atlantic, L.P.	Feb 11, 2025

Showing 1 to 4 of 4 entries

Schedules 13D/G Reported by General Atlantic, L.P.:

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.